State Pharmaceutical Corporation Produces Over 3.6 Billion Medicines

04-Jan-2026

.

The State Pharmaceutical Manufacturing Corporation of Sri Lanka has recorded an unprecedented achievement in its history by producing 3.625 billion units of medicines in 2025.

During the same period, the Corporation introduced five new pharmaceutical products to the market and generated revenue of Rs. 27.6 billion.

These details were revealed on Jan 2 during an event at which two newly manufactured medicines were officially handed over to the Minister of Health and Media, Nalinda Jayatissa. The two medicines were Methylprednisolone and Montelukast.

The Corporation fulfilled 100 percent of the medicine requirements of the State Pharmaceuticals Distribution Division last year. In March alone, it produced a record 385 million units, marking the highest monthly output in its history.

Additionally, the Corporation has obtained certification for Good Manufacturing Practices for the period from May 2025 to May 2027.

Addressing the event, Chairman Professor Jayantha Wijeyabandara stated that his objective is to manufacture internationally standard medicines at affordable prices. He noted that plans are underway to produce 4 billion units and introduce 10 new medicines in 2026.

He further stated that a new modern warehouse complex being constructed in Ratmalana is scheduled to be opened in March, while preliminary work is in progress to establish new manufacturing and packaging facilities in the Horana–Millawa area.

Targeting both local and international markets, the Corporation recorded an 85 percent improvement in its quality control systems last year and won several national and international awards.